@article{4853ea24061c44e3b8f38079bf1ebfd2,
title = "Antithrombotic therapy for patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention: a review.",
author = "Andrew Krasner and Halperin, \{Jonathan L.\}",
note = "Patients with atrial fibrillation who have risk factors for thromboembolism benefit from chronic oral anticoagulation therapy, and antiplatelet therapy alone is of relatively little benefit for prevention of ischemic stroke and systemic embolism. Patients undergoing percutaneous coronary intervention with drug-eluting stents require dual antiplatelet therapy with aspirin and a thienopyridine for 3 to 12 months or more prevention of stent thrombosis and recurrent ischemic events.",
year = "2013",
month = may,
day = "22",
doi = "10.1007/S11886-013-0378-Y",
language = "American English",
volume = "15",
journal = "Current Cardiology Reports",
number = "7",
}